Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

Emerging ‘co-scientist’ systems use teams of chatbots to mimic the deliberations of a research group. Do they really help?

Is it just age-related forgetfulness, or an early sign of something more serious? Neurologists outline the subtle differences ...

In OSA, oxygen desaturation respiratory events during REM sleep occur more often in Black adults, especially Black women, than in White adults.

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

In the Phase 2 MINDFuL trial of XProTM in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

In the Phase 2 MINDFuL trial of XPro in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat (mITT) population (n=200) did not meet the primary co ...

Dr Asad Khan is a respiratory consultant who retired on ill-health grounds due to Long Covid. He spoke to Solidarity about ...